PPMD was recently joined by Kathy Mathews, MD (Neurologist), Christina Trout, RN, MSN (Clinic Coordinator), and Rachel Kinn, PharmD, BCPPS (Pharmacist) from the University of Iowa to discuss decision making regarding steroids. In recent months we have learned there will soon be more steroid options clinically available to people living with Duchenne. We invited the University of Iowa team to walk us through considerations for initiating a new steroid drug and/or regimen, and the different processes for obtaining access to these medications.